Counterfeit, Unapproved and Diverted Drugs Threats & Monitoring Process
May 18, 2012
Introduction and Overview: The distribution and sales of Counterfeit, Unapproved and Diverted Drugs (CUDD) are a global concern for pharmaceutical patients, health care professionals, regulators and manufacturers. Counterfeit drugs are not equivalent to the genuine […]